| Chengdu D-innovation Pharmaceutical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (28) 8518-5760 (28) 8518-5486 | |||
![]() |
lillian@d-innovation.com sales@d-innovation.com | |||
![]() |
Skype Chat | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2009 | ||||
| Chiral Quest | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (512) 6936-9096 +86 18112603058 +86 18079165038 | |||
![]() |
tqli@cqpharm.com rppan@cqlonglife.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2009 | ||||
| Changzhou Carbochem Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (519) 8918-1862 +86 13775204319 | |||
![]() |
gao@carbo-chem.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2009 | ||||
| chemBlink standard supplier since 2010 | ||||
| Joyochem Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 13290333633 | |||
![]() |
sales@joyochem.com | |||
![]() |
QQ chat | |||
![]() |
WeChat: 13290333633 | |||
| Chemical manufacturer since 2010 | ||||
| chemBlink standard supplier since 2012 | ||||
| Arromax Pharmatech Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (512) 6295-4815 | |||
![]() |
sales@arromax.com | |||
| Chemical manufacturer since 2011 | ||||
| chemBlink standard supplier since 2013 | ||||
| Hangzhou Qichuang Chemical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (571) 8893-5129 | |||
![]() |
david@qc-chemical.com sales@qc-chemical.com davidw0828@gmail.com | |||
![]() |
QQ chat | |||
| Chemical distributor since 2009 | ||||
| chemBlink standard supplier since 2013 | ||||
| Hangzhou Leap Chem Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (571) 8771-1850 | |||
![]() |
market19@leapchem.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2006 | ||||
| chemBlink standard supplier since 2015 | ||||
| Shanghai Yingrui Biopharm Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (21) 3358-5366 3466-6753 +86 13311639313 | |||
![]() |
sales02@shyrchem.com | |||
![]() |
Skype Chat | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2009 | ||||
| chemBlink standard supplier since 2017 | ||||
| Classification | Natural product >> Steroidal compound |
|---|---|
| Name | 17-Iodoandrosta-5,16-dien-3beta-ol |
| Synonyms | (3S,8R,9S,10R,13S,14S)-17-iodo-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol |
| Molecular Structure | ![]() |
| Molecular Formula | C19H27IO |
| Molecular Weight | 398.32 |
| CAS Registry Number | 32138-69-5 |
| EC Number | 692-056-3 |
| SMILES | C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4I)C)O |
| Density | 1.5±0.1 g/cm3 Calc.* |
|---|---|
| Melting point | 175-176 ºC (Expl.) |
| Boiling point | 447.5±45.0 ºC 760 mmHg (Calc.)* |
| Flash point | 224.4±28.7 ºC (Calc.)* |
| Index of refraction | 1.618 (Calc.)* |
| * | Calculated using Advanced Chemistry Development (ACD/Labs) Software. |
| Hazard Symbols |
| ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Statements | H317-H360-H372-H400-H410 Details | ||||||||||||||||||||||||||||
| Precautionary Statements | P203-P260-P261-P264-P270-P272-P273-P280-P302+P352-P318-P319-P321-P333+P317-P362+P364-P391-P405-P501 Details | ||||||||||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||||||
|
17-Iodoandrosta-5,16-dien-3β-ol is a synthetic steroid derivative characterized by an iodinated modification at the 17-position of the androsta-5,16-dien backbone, with a 3β-hydroxyl group. The incorporation of iodine into the steroid nucleus confers distinctive chemical and biological properties, making the compound relevant for studies in steroid chemistry, radiolabeling, and receptor binding assays. Such iodinated steroids are often utilized as intermediates in the synthesis of radiolabeled analogs for imaging or mechanistic investigations of steroid hormone pathways. The discovery of 17-iodoandrosta-5,16-dien-3β-ol stems from research into functionalized steroid derivatives, particularly for use in receptor binding studies and chemical biology. The introduction of the iodine atom at C17 is typically achieved via halogenation reactions of corresponding 17-keto or 17-hydroxy steroid precursors under controlled conditions, ensuring regioselectivity and retention of the stereochemistry at C3. The double bonds at positions 5 and 16 contribute to the conjugated diene system, which can influence the molecule’s reactivity and interaction with steroid receptors. In synthetic chemistry, 17-iodoandrosta-5,16-dien-3β-ol serves as a versatile intermediate. The C17 iodide can participate in nucleophilic substitution, cross-coupling reactions, or radiolabeling with iodine isotopes such as 123I or 125I. These transformations allow the preparation of labeled steroids for positron emission tomography (PET) or single-photon emission computed tomography (SPECT) imaging, facilitating the study of steroid metabolism and receptor distribution in vivo. The 3β-hydroxyl group can also undergo selective derivatization to produce esters, ethers, or conjugates, expanding the range of chemical modifications possible. The compound’s structural features make it a useful probe in endocrinology and pharmacology. Iodinated steroids like 17-iodoandrosta-5,16-dien-3β-ol can bind to androgen or other nuclear receptors, enabling investigations into receptor affinity, selectivity, and signaling. Additionally, its functionalization at C17 allows the incorporation of radiotracers without significantly altering receptor binding characteristics, making it suitable for mechanistic and imaging studies in both cell-based and in vivo systems. The preparation of 17-iodoandrosta-5,16-dien-3β-ol generally involves careful control of reaction conditions to prevent side reactions such as overhalogenation or double-bond migration. Protection of the 3β-hydroxyl group is often employed during iodination to ensure selectivity, followed by deprotection to yield the free alcohol. The resulting compound is typically isolated as a crystalline solid or purified by chromatography, depending on the scale and desired purity. Applications of 17-iodoandrosta-5,16-dien-3β-ol extend to research in steroid biosynthesis and metabolism, where iodinated derivatives are used to track enzymatic transformations or receptor interactions. Its ability to serve as a precursor for radiolabeled analogs enhances its utility in medical imaging and diagnostic studies, providing insights into endocrine function, hormone-dependent cancers, and steroid pharmacokinetics. Overall, 17-iodoandrosta-5,16-dien-3β-ol is a functionally versatile steroid derivative with applications in synthetic chemistry, receptor binding studies, and radiolabeling. Its structural characteristics, including the C17 iodide, conjugated dienes, and 3β-hydroxyl group, make it a valuable tool for both chemical and biological investigations of steroid-related processes. |
| Market Analysis Reports |
| List of Reports Available for 17-Iodoandrosta-5,16-dien-3beta-ol |